For Rick Lui, a decision to take a one-year break from university in 2021 is starting to pay off. A…
Read More »biotech
China’s biotechnology merger and acquisition (M&A) transactions have almost doubled this year, with interest perking up among investors amid a…
Read More »Chinese tech giant Baidu is in talks with investors to raise up to US$2 billion over three years for a…
Read More »Evive Biotech, a unit of Shenzhen-listed Yifan Pharmaceutical, aims to break the dominance of American drugs developer Amgen in the…
Read More »China’s fragmented outsourced drug discovery services market will see further consolidation as companies seek to grab market share amid a…
Read More »Hutchison China MediTech (Chi-Med), whose stock has surged 70 per cent in London over the past six months, expects to…
Read More »Novoheart Holdings, the inventor of artificial “mini-hearts” co-founded by a Hong Kong scientist, is expanding its research and manufacturing budget…
Read More »